Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for Prevention of Post Dural Puncture Headache
NCT01503788Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Feb 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midazolam in post-dural puncture headache (PDPH), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
midazolam
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT01503788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01503788.